New Data Validates Evaxion AI Platform to Reduce Risk, Cost in Infectious Disease Vaccine Development

• Evaxion is the first organization to validate an AI model that outcompetes state-of-the-art vaccine development
• Evaxion's AI model predicts vaccine efficacy in infectious disease models
• These results mean using EDEN^TM will allow for a faster, cheaper, and lower-risk vaccine development compared to current approaches

https://www.biospace.com/article/releases/revolutionizing-vaccine-discovery-new-data-validates-evaxion-ai-platform-offering-promise-to-reduce-risk-and-cost-in-infectious-disease-vaccine-development/